Koninklijke Philips Operating Expenses 2012-2026 | PHG

Koninklijke Philips annual/quarterly operating expenses history and growth rate from 2012 to 2026. Operating expenses can be defined as the sum of all operating expenses for the given industry.
  • Koninklijke Philips operating expenses for the quarter ending March 31, 2026 were $4.288B, a 3.26% increase year-over-year.
  • Koninklijke Philips operating expenses for the twelve months ending March 31, 2026 were $18.702B, a 9.03% increase year-over-year.
  • Koninklijke Philips annual operating expenses for 2025 were $18.566B, a 1.91% decline from 2024.
  • Koninklijke Philips annual operating expenses for 2024 were $18.928B, a 4.35% decline from 2023.
  • Koninklijke Philips annual operating expenses for 2023 were $19.789B, a 2.96% decline from 2022.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Koninklijke Philips Annual Operating Expenses
(Millions of US $)
2025 $18,566
2024 $18,928
2023 $19,789
2022 $20,392
2021 $19,643
2020 $20,553
2019 $19,977
2018 $19,372
2017 $18,382
2016 $25,047
2015 $25,819
2014 $27,789
2013 $28,343
2012 $30,555
2011 $30,005
Koninklijke Philips Quarterly Operating Expenses
(Millions of US $)
2026-03-31 $4,288
2025-12-31 $5,300
2025-09-30 $4,644
2025-06-30 $4,469
2025-03-31 $4,153
2024-09-30 $4,441
2024-06-30 $3,926
2023-06-30 $4,632
2023-03-31 $5,099
2022-06-30 $4,433
2021-06-30 $4,994
2020-06-30 $4,587
2019-06-30 $4,858
2018-06-30 $4,758
2017-06-30 $4,446
2016-12-31 $6,940
2016-09-30 $6,043
2016-06-30 $6,197
2016-03-31 $5,867
2015-12-31 $7,615
2015-09-30 $6,113
2015-06-30 $6,222
2015-03-31 $5,869
2014-12-31 $6,932
2014-09-30 $7,481
2014-06-30 $6,806
2014-03-31 $6,570
2013-12-31 $8,254
2013-09-30 $6,828
2013-06-30 $6,719
2013-03-31 $6,542
2012-12-31 $9,545
2012-09-30 $7,251
2012-06-30 $6,982
2012-03-31 $6,778
2011-12-31 $8,838
2011-09-30 $7,248
2011-06-30 $7,167
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $27.260B $20.173B
Koninklijke Philips N.V. is the parent company of the Philips Group. The company realigned its three reporting operations into Diagnosis & Treatment businesses consists of Diagnostic Imaging, Ultrasound, Image-Guided Therapy and Enterprise Diagnostic Informatics businesses. Connected Care business comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, Sleep & Respiratory Care and Connected Care Informatics businesses. Personal Health business consists of the Oral Healthcare, Mother & Child Care and Personal Care. Other consists of Innovation, Emerging Businesses, IP Royalties, Central costs and Other. Notably, Philips completed the divestiture of Domestic Appliances business.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $174.688B 19.48
Stryker (SYK) United States $129.889B 24.88
Medtronic (MDT) Ireland $111.968B 15.57
EssilorLuxottica (ESLOY) France $107.724B 0.00
Boston Scientific (BSX) United States $91.831B 20.26
Medline (MDLN) United States $59.904B 0.00
Lonza Group Ag (LZAGY) Switzerland $45.712B 0.00
GE HealthCare Technologies (GEHC) United States $33.391B 15.98
ResMed (RMD) United States $33.341B 22.26
Agilent Technologies (A) United States $32.516B 20.44
Terumo (TRUMY) Japan $19.854B 23.21
Zimmer Biomet Holdings (ZBH) United States $18.025B 11.36
Smith & Nephew SNATS (SNN) United Kingdom $14.227B 0.00
Insulet (PODD) United States $13.640B 39.54
Baxter (BAX) United States $8.854B 7.56
Sunny Optical Technology (SNPTF) China $8.381B 0.00
Bio-Rad Laboratories (BIO) United States $7.537B 28.15
Demant (WILYY) Denmark $6.395B 0.00
Lantheus Holdings (LNTH) United States $5.247B 15.90
Envista Holdings (NVST) United States $4.301B 21.99
BillionToOne (BLLN) United States $3.729B 0.00
DiaSorin S.p.A (DSRLF) Italy $3.666B 0.00
ICU Medical (ICUI) United States $3.141B 20.47
Prestige Consumer Healthcare (PBH) United States $2.676B 12.62
Haemonetics (HAE) United States $2.664B 11.65
LeMaitre Vascular (LMAT) United States $2.611B 48.16
Phibro Animal Health (PAHC) United States $2.347B 20.67
GN Store Nord (GNNDY) Denmark $2.270B 21.90
Neogen (NEOG) United States $2.050B 44.86
Shandong Weigao Medical Polymer (SHWGF) China $2.028B 0.00
Capricor Therapeutics (CAPR) United States $1.794B 0.00
AdaptHealth (AHCO) United States $1.654B 32.89
Curaleaf Holdings (CURLF) Canada $1.584B 0.00
Perrigo (PRGO) Ireland $1.495B 3.96
AtriCure (ATRC) United States $1.429B 0.00
Green Thumb Industries (GTBIF) United States $1.386B 15.91
Kestra Medical Technologies (KMTS) United States $1.043B 0.00
BioLife Solutions (BLFS) United States $0.953B 164.50
QuidelOrtho (QDEL) United States $0.943B 6.53
Lumexa Imaging Holdings (LMRI) United States $0.896B 0.00
InMode (INMD) Israel $0.857B 9.40
Omeros (OMER) United States $0.827B 6.49
Maravai LifeSciences Holdings (MRVI) United States $0.789B 0.00
Tilray Brands (TLRY) Canada $0.766B 0.00
CeriBell (CBLL) United States $0.683B 0.00
Brainsway (BWAY) Israel $0.546B 55.68
Valneva SE (VALN) France $0.532B 0.00
VAREX IMAGING (VREX) United States $0.468B 11.18
Cresco Labs (CRLBF) United States $0.458B 0.00
Canopy Growth (CGC) Canada $0.424B 0.00
Verano Holdings (VRNO) United States $0.415B 0.00
Viemed Healthcare (VMD) United States $0.367B 25.70
SNDL (SNDL) Canada $0.366B 0.00
Cerus (CERS) United States $0.363B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.311B 126.00
Evolus (EOLS) United States $0.278B 0.00
TriSalus Life Sciences (TLSI) United States $0.259B 0.00
MacroGenics (MGNX) United States $0.229B 0.00
Owens & Minor (OMI) United States $0.217B 2.17
Accendra Health (ACH) United States $0.215B 2.96
Utah Medical Products (UTMD) United States $0.210B 18.94
High Tide (HITI) Canada $0.205B 0.00
OraSure Technologies (OSUR) United States $0.205B 0.00
Aurora Cannabis (ACB) Canada $0.194B 57.17
TerrAscend (TSNDF) Canada $0.193B 0.00
Organigram Global (OGI) Canada $0.191B 0.00
Apyx Medical (APYX) United States $0.166B 0.00
Quanterix (QTRX) United States $0.158B 0.00
Quipt Home Medical (QIPT) United States $0.157B 0.00
Sanara MedTech (SMTI) United States $0.152B 0.00
Sanuwave Health (SNWV) United States $0.145B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.143B 0.00
Vireo Growth (VREOF) United States $0.133B 0.00
Fonar (FONR) United States $0.115B 16.53
Jushi Holdings (JUSHF) United States $0.101B 0.00
FitLife Brands (FTLF) United States $0.090B 11.73
Exagen (XGN) United States $0.073B 0.00
Sharps Technology (STSS) United States $0.065B 0.00
ImmuCell (ICCC) United States $0.064B 0.00
Biote (BTMD) United States $0.063B 3.46
INLIF (INLF) China $0.053B 0.00
Cytosorbents (CTSO) United States $0.038B 0.00
Veru (VERU) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.036B 0.00
Nephros (NEPH) United States $0.032B 26.91
United-Guardian (UG) United States $0.030B 14.23
Bonk (BNKK) United States $0.021B 0.00
Jin Medical (ZJYL) China $0.018B 0.00
Modular Medical (MODD) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Flora Growth (FLGC) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Zynex (ZYXI) United States $0.004B 0.00
Functional Brands (MEHA) United States $0.003B 0.00
Agape ATP (ATPC) $0.003B 0.00
Meihua Medical Technologies (MHUA) China $0.002B 0.00
IM Cannabis (IMCC) Canada $0.002B 0.00
Akanda (AKAN) Canada $0.002B 0.00
GlucoTrack (GCTK) United States $0.001B 0.00
InterCure (INCR) Israel $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00
Trinity Biotech (TRIB) Ireland $0.000B 0.00